miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control

  • Authors:
    • Chiara Novello
    • Laura Pazzaglia
    • Chiara Cingolani
    • Amalia Conti
    • Irene Quattrini
    • Maria Cristina Manara
    • Mauro Tognon
    • Piero Picci
    • Maria Serena Benassi
  • View Affiliations

  • Published online on: November 28, 2012     https://doi.org/10.3892/ijo.2012.1717
  • Pages: 667-675
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

miRNA profile deregulation affecting downstream signaling pathways activates endpoints that represent potential biomarkers for prognosis and treatment of tumor patients. In the past 20 years conventional therapy for osteosarcoma (OS) reached a survival plateau, highlighting the need for new therapeutic approaches. In this study, microarray unsupervised and supervised analysis identified, respectively, 100 and 40 differentially expressed miRNAs in OS samples with different grades of malignancy compared to normal bone. When analyzing low-grade and high-grade OS by unsupervised analysis, 12 miRNAs were found to be differentially expressed. Real‑time PCR performed on a larger series of OS confirmed a significant lower expression of miR-1, miR‑133b and miR-378* in tumors with respect to control, also showing lower mRNA levels in 31 high-grade OS than in 25 low-grade and in metastatic versus non‑metastatic patients. We demonstrated that miR-1 and miR133b were downregulated in OS cell lines compared to normal osteoblasts. Secondly, by transfection with miRNA precursor molecules, we demonstrated that the ectopic expression of miR-1 and miR-133b in U2-OS cell lines significantly reduced cell proliferation and MET protein expression and negatively regulated cell invasiveness and motility in a short-term assay. Cell cycle distribution revealed block in G1 and delay of cell cycle progression associated with increased apoptosis in miR-1- and miR‑133b‑transfected cells, respectively. Our data assessed specific miRNA profiling deregulation in OS clinical samples and suggest that the expression of miR-1 and miR-133b may control cell proliferation and cell cycle through MET protein expression modulation.
View Figures
View References

Related Articles

Journal Cover

February 2013
Volume 42 Issue 2

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Novello, C., Pazzaglia, L., Cingolani, C., Conti, A., Quattrini, I., Manara, M.C. ... Benassi, M.S. (2013). miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control. International Journal of Oncology, 42, 667-675. https://doi.org/10.3892/ijo.2012.1717
MLA
Novello, C., Pazzaglia, L., Cingolani, C., Conti, A., Quattrini, I., Manara, M. C., Tognon, M., Picci, P., Benassi, M. S."miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control". International Journal of Oncology 42.2 (2013): 667-675.
Chicago
Novello, C., Pazzaglia, L., Cingolani, C., Conti, A., Quattrini, I., Manara, M. C., Tognon, M., Picci, P., Benassi, M. S."miRNA expression profile in human osteosarcoma: Role of miR-1 and miR-133b in proliferation and cell cycle control". International Journal of Oncology 42, no. 2 (2013): 667-675. https://doi.org/10.3892/ijo.2012.1717